Conversion of the Laboratory Synthetic Route of the N-Aryl-2-benzothiazolamine R116010 to a Manufacturing Method
- 25 July 2001
- journal article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 5 (5) , 467-471
- https://doi.org/10.1021/op0100201
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Liarozole fumarate (R85246): a novel imidazole in the treatment of receptor positive postmenopausal metastatic breast cancerBreast Cancer Research and Treatment, 2000
- The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancerCancer, 1998
- Dynamic diastereomeric salt resolution of narwedine and its transformation to (−)-galanthamineTetrahedron Letters, 1998
- The antiproliferative activity of all-trans-retinoic acid catabolites and isomers is differentially modulated by liarozole-fumarate in MCF-7 human breast cancer cellsBritish Journal of Cancer, 1998
- Synthesis of LIAZALTM, a retinoic acid metabolism blocking agent (ramba) with potential clinical applications in oncology and dermatologyBioorganic & Medicinal Chemistry Letters, 1998
- Synthesis of N-benzyl-3-(S)-(+)-(4-fluorophenyl)-1,4-oxazin-2-one via a crystallisation induced asymmetric transformationTetrahedron: Asymmetry, 1997
- LiarozoleDrugs & Aging, 1996
- Stereo- and regioselective synthesis of chiral diamines and triamines from pseudoephedrine and ephedrineThe Journal of Organic Chemistry, 1992
- Silafunctional compounds in organic synthesis. 33. Metalated allylaminosilane: a new, practical reagent for the stereoselective .alpha.-hydroxyallylation of aldehydes to erythro-1,2-diol skeletonsThe Journal of Organic Chemistry, 1987
- Acetyldiarylamines by arylation of acetanilides. Some applications and limitationsThe Journal of Organic Chemistry, 1978